Christopher W. Gregory
Papers
1
Total Citations
70
H-Index
1
About
Christopher W. Gregory is a prominent figure in prostate cancer research, with a primary focus on the molecular mechanisms driving androgen-independent tumor progression. His seminal work, particularly the 2002 study on androgen receptor expression and cellular proliferation in the CWR22 xenograft model, has been cited over 70 times and remains a cornerstone in understanding how prostate cancers transition from hormone-sensitive to castration-resistant growth. Gregory’s research elucidates the critical role of androgen receptor amplification and sustained signaling even after androgen deprivation therapy, offering key insights into therapeutic resistance. Beyond this landmark paper, his contributions have shaped the field’s understanding of tumor microenvironment interactions and the genetic adaptations that enable recurrent growth. His work is widely recognized for bridging basic molecular biology with clinical implications, making him an influential voice in the development of next-generation hormonal therapies. For students and researchers delving into prostate cancer biology, Gregory’s studies provide essential foundational knowledge on the adaptive pathways that challenge current treatment paradigms.
Research Focus
Key Achievements
Top Papers
- 1